drugset / Trial / NCT06152458

Blessing or Curse? Combined Vitamin Therapy in Non Viral Septic Shock.

NCT06152458

Phase 4 Completed 43 enrolled University of Pecs
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Introduction: Septic shock leads to high morbidity and mortality in critically ill patients. Several lower-case scientific studies have supported the synergistic positive effect of vitamin C, thiamine, and hydrocortisone on sepsis-induced organ dysfunction. Aim: Our aim was to investigate the effect of vitamin complex on organ failure, laboratory parameters, respiratory and antibiotic treatment, intensive care time, and mortality in septic shock patients. Material and methods: In our retrospective and prospective analysis, we collected parameters from 43 (23 vitamin-treated, 20 control) septic shock patients. Patients treated with vitamin, they received vitamin C (4x1500 mg), thiamine (2x200 mg) for three days (2). In other respects, and for hydrocortisone (200 mg / 24h), both groups of patients received treatment according to the European Sepsis Recommendation. SPSS (V-21) data were used for data collection, Kolmogorov-Smirnov, Wilcoxon, Mann-Whitney U tests were used for statistical analysis. Ethical license: 7849-PTE 2019.

Timeline

Start
2019-01-01
Primary completion
2020-03-01
Completion
2020-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Thiamine Other / unclassified 200 mg
Subject Vitamin C Other / unclassified 1.5 g Intravenous